Ordinance
on Licensing in the Medicinal Products Sector
(Medicinal Products Licensing Ordinance, MPLO)

of 14 November 2018 (Status as of 23 January 2023)


Open article in different language:  DE  |  FR  |  IT
Art. 14 Reanalysis

If ready-to-use medi­cin­al products are man­u­fac­tured in a State with which Switzer­land has not signed an agree­ment on the mu­tu­al re­cog­ni­tion of the GMP con­trol pro­ced­ures and there are jus­ti­fied doubts about the safety or qual­ity of the batches to be im­por­ted, Swiss­med­ic may or­der that each batch un­der­go reana­lys­is in Switzer­land.

Previous article Show article in the law Next article

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Gesetzeskürzel Name
DE FR IT EN
DE FR IT EN
Laden